Hong Kong · Delayed Price · Currency is HKD Theseus Pharmaceuticals Statistics
Total Valuation
HKG:2888 has a market cap or net worth of HKD 332.12 billion.
| Market Cap | 332.12B |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Mar 26, 2025 |
Share Statistics
| Current Share Class | 2.30B |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -8.35% |
| Shares Change (QoQ) | -1.70% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.84B |
Valuation Ratios
The trailing PE ratio is 9.42 and the forward PE ratio is 8.79.
| PE Ratio | 9.42 |
| Forward PE | 8.79 |
| PS Ratio | 2.10 |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.03 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 9.43%.
| Return on Equity (ROE) | 9.43% |
| Return on Assets (ROA) | 0.57% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 1.96M |
| Profits Per Employee | 436,687 |
| Employee Count | 81,145 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HKG:2888 has paid 14.96 billion in taxes.
| Income Tax | 14.96B |
| Effective Tax Rate | 27.60% |
Stock Price Statistics
The stock price has increased by +109.94% in the last 52 weeks. The beta is 0.68, so HKG:2888's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | +109.94% |
| 50-Day Moving Average | 132.43 |
| 200-Day Moving Average | 111.32 |
| Relative Strength Index (RSI) | 67.44 |
| Average Volume (20 Days) | 1,880,413 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2888 had revenue of HKD 157.94 billion and earned 35.24 billion in profits. Earnings per share was 14.12.
| Revenue | 157.94B |
| Gross Profit | 157.94B |
| Operating Income | 59.35B |
| Pretax Income | 54.20B |
| Net Income | 35.24B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 14.12 |
Balance Sheet
The company has 2.91 trillion in cash and 1.67 trillion in debt, giving a net cash position of 1.24 trillion.
| Cash & Cash Equivalents | 2.91T |
| Total Debt | 1.67T |
| Net Cash | 1.24T |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 429.16B |
| Book Value Per Share | 152.40 |
| Working Capital | -3,033.21B |
Cash Flow
In the last 12 months, operating cash flow was -233.07 billion and capital expenditures -3.96 billion, giving a free cash flow of -237.03 billion.
| Operating Cash Flow | -233.07B |
| Capital Expenditures | -3.96B |
| Free Cash Flow | -237.03B |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | 37.57% |
| Pretax Margin | 34.32% |
| Profit Margin | 24.76% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 2.87, which amounts to a dividend yield of 2.02%.
| Dividend Per Share | 2.87 |
| Dividend Yield | 2.02% |
| Dividend Growth (YoY) | 36.01% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 27.93% |
| Buyback Yield | 8.35% |
| Shareholder Yield | 10.37% |
| Earnings Yield | 10.61% |
| FCF Yield | -71.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |